Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

被引：77

作者：

Wang, Michael ^{[1
]}

Rule, Simon ^{[2
]}

Zinzani, Pier Luigi ^{[3
]}

Goy, Andre ^{[4
]}

Casasnovas, Olivier ^{[5
]}

Smith, Stephen D. ^{[6
]}

Damaj, Gandhi ^{[7
]}

Doorduijn, Jeanette K. ^{[8
]}

Lamy, Thierry ^{[9
]}

Morschhauser, Franck ^{[10
]}

Panizo, Carlos ^{[11
]}

Shah, Bijal ^{[12
]}

Davies, Andrew ^{[13
]}

Eek, Richard ^{[14
]}

Dupuis, Jehan ^{[15
]}

Jacobsen, Eric ^{[16
]}

Kater, Arnon P. ^{[17
]}

Le Gouill, Steven ^{[18
]}

Oberic, Lucie ^{[19
]}

Robak, Tadeusz ^{[20
]}

Jain, Preetesh ^{[1
]}

Frigault, Melanie M. ^{[21
]}

Izumi, Raquel ^{[21
]}

Dorothy Nguyen ^{[21
]}

Patel, Priti ^{[21
]}

Yin, Ming ^{[21
]}

Dlugosz-Danecka, Monika ^{[22
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Plymouth Univ, Sch Med, Plymouth, Devon, England

[3] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

[4] Hackensack Univ Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[5] Hop Enfants, CHU Dijon, Dijon, France

[6] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

[7] Inst Hematol Basse Normandie, Caen, France

[8] Erasmus MC, HOVON Lunenburg Lymphoma Phase Consortium 1 2, Rotterdam, Netherlands

[9] CHU Rennes, Rennes, France

[10] Univ Lille, CHU Lille, GRITA Grp Rech Formes Injectables & Technol Assoc, EA 7365, F-59000 Lille, France

[11] Clin Univ Navarra, Pamplona, Spain

[12] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[13] Univ Southampton, Canc Res UK Ctr, Fac Med, Southampton, Hants, England

[14] Border Med Oncol, Albury, Vic, Australia

[15] Hop Henri Mondor, AP HP, Unite Hemopathies Lymphoides, Creteil, France

[16] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[17] Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam Univ Med Ctr, HOVON Lunenburg Lymphoma Phase Consortium 1 2, Amsterdam, Netherlands

[18] Hop Hotel Dieu, CHU Nantes, Nantes, France

[19] Inst Univ Canc Oncopole Toulouse, Toulouse, France

[20] Med Univ Lodz, Copernicus Mem Hosp, Lodz, Poland

[21] Acerta Pharma, San Francisco, CA USA

[22] Jagiellonian Univ, Dept Haematol, Krakow, Poland

来源：

LEUKEMIA | 2019年 / 33卷 / 11期

关键词：

IBRUTINIB;

D O I：

10.1038/s41375-019-0575-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2762 / 2766

页数：5

共 50 条

[31] Management of relapsed/refractory mantle cell lymphoma
Alzahrani, Musa
Villa, Diego
LEUKEMIA & LYMPHOMA, 2024, 65 (08) : 1044 - 1054
[32] TemsirolimusIn Relapsed and/or Refractory Mantle Cell Lymphoma
Sheridan M. Hoy
Kate McKeage
Drugs, 2010, 70 : 1819 - 1829
[33] Dismantling relapsed/refractory mantle cell lymphoma
Ryan, Christine E.
Kumar, Anita
BLOOD REVIEWS, 2024, 67
[34] Single-agent ibrutinib for the treatment of mantle cell lymphoma (MCL): evaluating the link between durable response and quality of life (QoL) in the SPARK study
Rule, S.
Goy, A.
Martin, P.
Ramchandren, R.
Alexeeva, J.
Popat, R.
Avivi, I.
Advani, R.
Le Gouill, S.
Horowitz, N.
Yuan, Z.
Kranenburg, B.
Zhuang, S. H.
Deraedt, W.
Rizo, A.
Wildgust, W.
Wang, M.
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 59 - 59
[35] Acalabrutinib in mantle cell lymphoma
Kapoor, Prashant
Ansell, Stephen M.
LANCET, 2018, 391 (10121): : 633 - 634
[36] Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial
Wang, Michael
Rule, Simon
Zinzani, Pier Luigi
Goy, Andre
Casasnovas, Olivier
Smith, Stephen D.
Damaj, Gandhi
Doorduijn, Jeanette
Lamy, Thierry
Morschhauser, Franck
Panizo, Carlos
Shah, Bijal
Davies, Andrew
Eek, Richard
Dupuis, Jehan
Jacobsen, Eric
Kater, Arnon P.
Le Gouill, Steven
Oberic, Lucie
Robak, Taduesz
Covey, Todd
Dua, Richa
Hamdy, Ahmed
Huang, Xin
Izumi, Raquel
Patel, Priti
Rothbaum, Wayne
Slatter, J. Greg
Jurczak, Wojciech
LANCET, 2018, 391 (10121): : 659 - 667
[37] Acalabrutinib for mantle cell lymphoma
Witzig, Thomas E.
Inwards, David
BLOOD, 2019, 133 (24) : 2570 - 2574
[38] Dacarbazine as Single-Agent Therapy for Relapsed Lymphoma in Dogs
Griessmayr, P. C.
Payne, S. E.
Winter, J. E.
Barber, L. G.
Shofer, F. S.
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (06): : 1227 - 1231
[39] Comparative Effectiveness of Single-Agent Ibrutinib in the Ray Trial Versus Real-World Treatment in the Lyon-Sud Database in Patients with Relapsed or Refractory Mantle Cell Lymphoma
Sarkozy, Clementine
Traverse-Glehen, Alexandra
Bachy, Emmanuel
Karlin, Lionel
Ghesquieres, Herve
Besson, Herve
Hermans, Ruben
Healy, Nollaig
Garside, Jamie
Diels, Joris
MacDougall, Finlay
Pick-Lauer, Corinna
Salles, Gilles
BLOOD, 2017, 130
[40] Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study
Goy, Andre
Sinha, Rajni
Williams, Michael E.
Besisik, Sevgi Kalayoglu
Drach, Johannes
Ramchandren, Radhakrishnan
Zhang, Lei
Cicero, Sherri
Fu, Tommy
Witzig, Thomas E.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3688 - +

← 1 2 3 4 5 →